David Wallach | Academic Influence

David Wallach's AcademicInfluence.com Rankings

David Wallach

Biology

#4241

World Rank

#6357

Historical Rank

Biochemistry

#786

World Rank

#891

Historical Rank

Molecular Biology

#915

World Rank

#938

Historical Rank

biology Degrees

Download Badge

Biology

David Wallach's Degrees

PhD Biochemistry Tel Aviv University
Bachelors Chemistry Tel Aviv University

Why Is David Wallach Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Wallach is a full professor at the Department of Biological Chemistry at Weizmann Institute of Science, Israel, laureate of the 2014 Emet Prize for Life Sciences. , and laureate of the 2018 The Paul Ehrlich and Ludwig Darmstaedter Prize.

(See a Problem?)

David Wallach's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (3106)
Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death (1996) (2412)
Tumor necrosis factor receptor and Fas signaling mechanisms. (1999) (1402)
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 (1997) (1389)
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. (1998) (1280)
A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) (1995) (1113)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination (2003) (1045)
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors (1992) (865)
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease (1994) (589)
Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. (1990) (550)
Elevated tumour necrosis factor‐alpha (TNF‐α) biological activity in psoriatic skin lesions (1994) (478)
A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. (1989) (445)
The CD95 Receptor: Apoptosis Revisited (2007) (403)
Programmed necrosis in inflammation: Toward identification of the effector molecules (2016) (402)
Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) (1995) (395)
Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 (2004) (390)
Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. (2013) (388)
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. (1990) (388)
Soluble cytokine receptors are present in normal human urine (1989) (379)
Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells (1982) (361)
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. (1992) (353)
CASH, a Novel Caspase Homologue with Death Effector Domains* (1997) (351)
Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. (2004) (336)
Induction of Interleukin-8 Synthesis Integrates Effects on Transcription and mRNA Degradation from at Least Three Different Cytokine- or Stress-Activated Signal Transduction Pathways (1999) (335)
Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. (1990) (326)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (323)
The death domain: a module shared by proteins with diverse cellular functions. (1995) (322)
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. (1980) (321)
Survival function of the FADD-CASPASE-8-cFLIP(L) complex. (2012) (296)
Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury (1996) (264)
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B‐like enhancer binding activity which displaces constitutive factors. (1989) (264)
Cell death induction by receptors of the TNF family: towards a molecular understanding (1997) (252)
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. (1991) (252)
CD27, a Member of the Tumor Necrosis Factor Receptor Superfamily, Activates NF-κB and Stress-activated Protein Kinase/c-Jun N-terminal Kinase via TRAF2, TRAF5, and NF-κB-inducing Kinase* (1998) (251)
Cell death induction by TNF: a matter of self control. (1997) (250)
MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation (2017) (240)
Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase (2004) (229)
Hsp90 Recognizes a Common Surface on Client Kinases* (2006) (227)
Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. (1982) (218)
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ (1999) (208)
Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. (1991) (204)
Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases (2004) (201)
RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. (2011) (195)
Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease (2009) (180)
Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. (1988) (178)
Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis (1999) (177)
Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity (1994) (167)
Tumor necrosis factor induction by Sendai virus. (1986) (162)
Epstein–Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ (1998) (159)
Variation in serum levels of the soluble TNF receptors among healthy individuals. (1992) (157)
Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. (1987) (157)
Preparations of lymphotoxin induce resistance to their own cytotoxic effect. (1984) (157)
INTRAMUSCULAR HUMAN INTERFERON-β INJECTIONS IN TREATMENT OF CONDYLOMATA ACUMINATA (1984) (142)
Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. (1992) (137)
Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. (2004) (135)
A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other (1996) (130)
CACHECTIN/TUMOUR-NECROSIS-FACTOR PRODUCTION BY CANCER PATIENTS (1985) (130)
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants (2003) (130)
Hijacking of Host Cell IKK Signalosomes by the Transforming Parasite Theileria (2002) (129)
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. (1998) (129)
Mutation of a Self-Processing Site in Caspase-8 Compromises Its Apoptotic but Not Its Nonapoptotic Functions in Bacterial Artificial Chromosome-Transgenic Mice1 (2008) (129)
Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. (2006) (129)
ASSAY OF AN INTERFERON-INDUCED ENZYME IN WHITE BLOOD CELLS AS A DIAGNOSTIC AID IN VIRAL DISEASES (1981) (126)
Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor (1988) (118)
Concepts of tissue injury and cell death in inflammation: a historical perspective (2013) (114)
Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway byCaspase-9 (2006) (113)
TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. (1994) (110)
Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it (2015) (106)
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD (2007) (106)
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development (2017) (106)
Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia (1996) (104)
Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. (1993) (100)
Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells. (1981) (96)
Concepts of tissue injury and cell death in inflammation: a historical perspective (2014) (95)
Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. (1994) (90)
Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict. (1998) (86)
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF‐R) in patients with HIV infection (1992) (86)
Differential regulation of HLA‐DR mRNAs and cell surface antigens by interferon. (1983) (85)
Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. (1995) (84)
Apoptosis: Placing death under control (1997) (83)
Role of caspase‐8 in hepatocyte response to infection and injury in mice (2007) (83)
Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. (1996) (78)
Soluble and cell surface receptors for tumor necrosis factor. (1991) (76)
The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products. (1981) (68)
Caspase-8 deficiency facilitates cellular transformation in vitro (2008) (65)
Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. (1990) (65)
Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon (1989) (64)
Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. (1999) (62)
Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. (1985) (61)
Tumor necrosis factor in middle ear effusions. (1988) (61)
Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. (1993) (59)
NF-κB-Inducing Kinase Is Involved in the Activation of the CD28 Responsive Element through Phosphorylation of c-Rel and Regulation of Its Transactivating Activity1 (2006) (59)
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. (1998) (58)
TRAF2 plays a dual role in NF‐κB‐dependent gene activation by mediating the TNF‐induced activation of p38 MAPK and IκB kinase pathways (1998) (57)
Soluble cytokine-receptors are present in normal human urine (1989) (56)
A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its ‘death domain’ (1995) (56)
Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. (1995) (55)
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta (1993) (55)
Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. (1995) (54)
Transcription-controlled gene therapy against tumor angiogenesis. (2004) (54)
Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis (1990) (49)
Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. (1985) (48)
The extrinsic cell death pathway and the élan mortel (2008) (47)
Delivery of Soluble Tumor Necrosis Factor Receptor from In-Situ Forming PLGA Implants: In-Vivo (2000) (47)
How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family (2002) (47)
Involvement of interferon in virus-induced lymphopenia. (1983) (46)
'Necrosome'-induced inflammation: must cells die for it? (2011) (46)
Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells. (1992) (45)
Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. (1993) (45)
If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation. (2006) (45)
Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. (1988) (44)
Binding of human TNF-α to high-affinity cell surface receptors: Effect of IFN (1986) (42)
The cybernetics of TNF: Old views and newer ones. (2016) (42)
Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages. (1993) (37)
Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family. (1996) (36)
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. (1993) (36)
Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. (1995) (35)
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells. (1993) (35)
Suicide by order: some open questions about the cell-killing activities of the TNF ligand and receptor families. (1996) (34)
Activation of the NLRP3 inflammasome by proteins that signal for necroptosis. (2014) (33)
Interferon-lnduced resistance to the killing by NK cells: A preferential effect of IFN-γ (1983) (32)
Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons. (1986) (31)
Dominant negative MORT1/FADD rescues mice from CD95 and TNF‐induced liver failure (2003) (30)
Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia. (1982) (30)
Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. (1988) (29)
The yeast two-hybrid screening technique and its use in the study of protein-protein interactions in apoptosis. (1998) (29)
Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3 (2018) (28)
Caspase-8 Is Involved in Neovascularization-Promoting Progenitor Cell Functions (2009) (27)
Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor. (1996) (27)
Up the down staircase (2002) (26)
Functional discrepancies between tumor necrosis factor and lymphotoxin α explained by trimer stability and distinct receptor interactions (1995) (26)
An interferon-induced cellular enzyme is incorporated into virions (1980) (25)
Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. (1995) (24)
TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways. (1998) (24)
Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection. (1982) (23)
Interferon-induced enzymes: microassays and their applications: purification and assay of (2'-5')-oligoadenylate synthetase and assay of 2'-phosphodiesterase. (1981) (22)
Programmed Cell Death in Immune Defense: Knowledge and Presumptions. (2018) (22)
The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies. (2018) (22)
Aderka, D. et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor- or -. Blood 81, 2076−2084 (1993) (21)
Enhanced release of lymphotoxins by interferon-treated cells. (1983) (21)
Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons. (1982) (21)
How do cells sense foreign DNA? A new outlook on the function of STING. (2013) (20)
Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation. (2006) (20)
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2. (1992) (19)
Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis. (1995) (19)
Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice. (1993) (19)
The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2–p36.3 (1991) (19)
The TNF cytokine family: one track in a road paved by many. (2013) (18)
The in vivo significance of necroptosis: lessons from exploration of caspase-8 function. (2014) (17)
Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma. (1983) (16)
Expression of cytokines, growth factors, and their receptors in renal allograft biopsies. (1993) (16)
MORT1/FADD is involved in liver regeneration. (2005) (16)
Keeping inflammation at bay (2014) (16)
Epstein – Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NFk B through a pathway that includes the NFk B-inducing kinase and the I k B kinases IKK a and IKK b (1998) (15)
Phosphorylation and dephosphorylation of the RIG-I-like receptors: a safety latch on a fateful pathway. (2013) (14)
Cloning, sequencing and partial functional characterization of the 5' region of the human p75 tumor necrosis factor receptor-encoding gene (TNF-R). (1994) (14)
Inhibition by glucocorticosteroid hormones of interferon and prostaglandin E induction by poly(rI). Poly(rC). (1982) (13)
Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy. (1993) (13)
12th international TNF conference: the good, the bad and the scientists. (2009) (13)
Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice. (1992) (12)
Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy (1987) (12)
The HLA proteins and a related protein of 28 kDa are preferentially induced by interferon‐γ in human WISH cells (1983) (12)
Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection. (1995) (11)
Cell-autonomous and non-cell-autonomous functions of caspase-8. (2008) (11)
The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13 (1991) (11)
Hormonal protection of interferon‐treated cells against double‐stranded RNA‐induced cytolysis (1979) (10)
Self-termination of the terminator (2008) (10)
Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines. (1984) (10)
(2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections. (1984) (10)
A decade of accumulated knowledge and emerging answers. The 6th international congress on TNF Rhodes, Greece. May 1996. (1996) (10)
Mechanisms which take part in regulation of the response to tumor necrosis factor. (1989) (10)
Induction of hyporesponsiveness to an early post‐binding effect of tumor necrosis factor by tumor necrosis factor itself and interleukin 1 (1991) (9)
Recombinant interferon alpha‐C for advanced hairy cell leukemia. An Israeli multicenter study (1988) (9)
Soluble Tumor Necrosis Factor Receptors in Health and Disease (1993) (9)
Anti‐inflammatory functions of the “apoptotic” caspases (2010) (9)
Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins. (1983) (8)
Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN. (1986) (8)
Site-specific ubiquitination of MLKL targets it to endosomes and targets Listeria and Yersinia to the lysosomes (2022) (8)
Inhibition of tumor necrosis factor-induced cell killing by tryptophan and indole. (1990) (8)
Cell Surface and Soluble TNF Receptors1 (1992) (7)
Interactions of Tumor Necrosis Factor, Interferon and Interleukin-1 in Cell Killing (1987) (6)
Increased Serum Levels of Soluble Receptors for Tumor Necrosis Factor in Cancer (1991) (5)
The TNF family: only the surface has been scratched. (2014) (5)
Regulation of the Response to Tumor Necrosis Factor (1988) (5)
Translation of mRNA for human lymphotoxin in microinjected Xenopus oocytes (1984) (4)
An immunoenzyme quantitative assay for the antiviral effect of interferons. (1984) (4)
Involvement of cytotoxins in the immune response to viral infection. (1985) (4)
Interferon as a possible cause for virus-related lymphocytopenia. (1982) (4)
Cloning of genomic DNA for tumor necrosis factor and efficient expression in CHO cells. (1988) (4)
Probing cell death by chemical screening (2005) (4)
High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men. (1996) (4)
Soluble cytokine receptors in normal human urine (1990) (4)
Suppressive effect of TNF-α and IL-1 on alveolar fibroblast proliferation in sarcoidosis (1992) (4)
Nonapoptotic Roles Caspase-8 Serves Both Apoptotic And (2004) (3)
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma (2011) (3)
Implications for persistent chlamydial infections of phagocyte-microorganism interplay (1991) (3)
Presence of Tumor Necrosis Factor and Lymphotoxin in Clinical Interferon Preparations Derived from Leukocytes (1987) (3)
Diverse Functions of the Tumor Necrosis Factor Receptors: Structure-Activity Considerations (1993) (2)
Mechanisms controlling the level of receptors for tumor necrosis factor (2005) (2)
Mechanisms Involved in Regulation of the Response to Tumor Necrosis Factor (1990) (2)
Screening for proteins that bind to the intracellular domains of the two tumor necrosis factor receptors (TNF-R) revealed effective self-association of the p55 TNF-R “death domain”, which can trigger signaling (1994) (2)
Anti-inflammatory functions of caspase-8. (2011) (2)
Artificial Chromosome-Transgenic Mice Not Its Nonapoptotic Functions in Bacterial Caspase-8 Compromises Its Apoptotic but Mutation of a Self-Processing Site in (2008) (2)
Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C. (1985) (2)
INTERFERON-INDUCED PROTEINS: BIOLOGICAL FUNCTIONS AND CLINICAL APPLICATIONS (1982) (2)
Identification of viral infections in pregnancy by assay of (2'-5')-oligo-isoadenylate synthetase. (1985) (1)
Roles of TNF and Other Members of the TNF Family in the Regulation of Innate Immunity (2016) (1)
Increase of Vulnerability to Lymphotoxin in by Vesicular Stomatitis Virus and Its Augmentation by Interferon' Cells Infected Further (1985) (1)
Correction for Gyrd-Hansen et al., “Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9” (2017) (1)
Up the down staircase (2002) (1)
NF-κB stimulatory pathways linked by a common kinase (1997) (1)
Tumor necrosis factor receptors of the monocyte derived Langerhans cell phenotype "MoLC". (1995) (1)
Sensitizing effects and mechanisms of desensitization in regulation of the in vivo response to TNF. (1988) (1)
Faculty Opinions recommendation of Mixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury. (2018) (1)
Tumor necrosis factor-binding protein II, its purification and specific antibodies. (1990) (0)
Caspase-8 regulates cellular response to pattern recognition receptors and prevents spontaneous triggering of chronic inflammation by their endogenous activators (2009) (0)
Faculty Opinions recommendation of Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. (2005) (0)
Molecule influencing shedding of tnf receptor, its preparation and its use (1994) (0)
Cytokine Receptors, Soluble (1998) (0)
Using Antizytokin-containing pharmaceutical compositions for the treatment of multiple sclerosis (1992) (0)
969. Transcription Controlled Gene Therapy Against Tumor Angiogenesis (2004) (0)
The Role of Tumor Necrosis Factor in Human Granulosa Cells and Early Embryo (1990) (0)
Faculty Opinions recommendation of Interchain proteolysis, in the absence of a dimerization stimulus, can initiate apoptosis-associated caspase-8 activation. (2005) (0)
Faculty Opinions recommendation of Telomerase directly regulates NF-κB-dependent transcription. (2012) (0)
TNF receptors on rat brain oligodendrocytes: Implications for nerve regeneration (1991) (0)
Putative role of tumor necrosis factor in the loss of dopaminergic neurons in Parkinson's disease (1992) (0)
PROTEINE IREN (IλB REGULATOR), PRODUCTION ET UTILISATION (2000) (0)
Materials and Methods Isolation and Ex Vivo Endothelial Differentiation of Human Endothelial Progenitor Cells (2009) (0)
Modulators function fas receptor and other proteins. (1996) (0)
Modulators of receptor function of TNF receptor family / NGF. (1999) (0)
Anticorps diriges contre nik, preparation et emploi (2004) (0)
The use of pharmaceutical compositions comprising an anticytokine, for the treatment of multiple sclerosis (1992) (0)
Proceedings of the 12th International TNF Conference, 2009. (2011) (0)
II binding proteins to Tumor Necrosis Factor, its purification and antibodies thereto (1990) (0)
Comprar Advances In Tnf Family Research. Proceedings Of The 12th International Tnf Conference, 2009 (Advances In Experimental Medicine And Biology, Vol. 691) | Andrew Kovalenko | 9781441966117 | Springer (2010) (0)
International Review of Cytology. Supplement 12: Membrane Research-Classic Origins and Current Concepts.G. H. Bourne , J. F. Danielli (1983) (0)
Faculty Opinions recommendation of Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. (2004) (0)
Increased Serum Levels of Soluble Receptors for Tumor Necrosis Factor in Cancer Patients1 (2006) (0)
The use of interleukin-6 for the preparation of a pharmaceutical composition for the treatment of lymphocytic leukemia and B-cell lymphoma. (1992) (0)
Modulating the action of TNF receptor. (1993) (0)
Modulating the function of the Fas / APO1 receptors. (1995) (0)
Abstract 1302: Caspase-8-dependent Cleavage Of The E3 Ubiquitin Ligase Cbl-b Regulates Integrin Expression And Adhesion Capacity In Endothelial Progenitor Cells (2007) (0)
Human natural ifn-bata2/il-6 receptor (1990) (0)
Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3 (2018) (0)
Expression of the binding protein i to tumor necrosis factor TBP-I recombinant. (1990) (0)
Arzneitmittel for controlled release of soluble receptors (1996) (0)
Ubiquitination related activity and / or degradation sive and modulators thereof. (2007) (0)
Promoters for p75 tumor necrosis factor. (1995) (0)
Purification of TNF binding proteins. (2004) (0)
A pharmaceutical composition comprising a cytokine (1992) (0)
Tumor Necrosis Factor Alpha (TNFalpha) (2016) (0)
Faculty Opinions recommendation of Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. (2005) (0)
Modulating the TNF receptor activity (1993) (0)
Regulation of Its Transactivating Activity through Phosphorylation of c-Rel and Activation of the CD 28 Responsive Element B-Inducing Kinase Is Involved in the κ NF - (2006) (0)
Derivatives of the NF-kappaB-inducing enzyme, the preparation and use thereof (2003) (0)
Pharmaceutical compositions containing a Anticytokin (1992) (0)
Faculty Opinions recommendation of RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. (2009) (0)
FADD is involved in liver regeneration (2014) (0)
Antibodies to TNF binding protein I and their F (ab) fragments. (1990) (0)
Interferon and lipoid nephrosis. (1988) (0)
11 Patent Number : 45 Date of Patent : 5 , 359 , 037 Oct . 25 , 1994 ons ' , in : Interferon 7 (2017) (0)
Modulators of the TNF receptor-associated factor whose preparation and uses (1997) (0)
Multimers of the soluble forms of the TNF receptors, to processes for their preparation and pharmaceutical compositions containing them (1992) (0)
Antibodies to protein which binds to TNF iya its F (ab). (1990) (0)
Abstract 997: A Novel Apoptosis-Unrelated Role of Caspase-8 in Endothelial Progenitor Cell-Mediated Neovascularization (2006) (0)
RESISTANCE TO NATURAL-KILLER CELLS' CYTOTOXICITY AND HLA SYNTHESIS: DIFFERING REGULATORY EFFICIENCY OF THE TYPE-I AND IMMUNE INTERFERONS (1982) (0)
Tumor necrosis factor binding protein II, it's purification and antibodies thereto (1990) (0)
TNF receptor-modulating effect (1993) (0)
69 Structure–Function Analysis In Vivo of Cytokine-Mediated Cell-Death Induction: BAC Transgenic Mice of Caspase-8 Mutants (2007) (0)
SIGNALING MECHANISMS ACTIVATED BY RECEPTORS OF THE TNF/NGF FAMILY: 296 (1997) (0)
pharmaceutical compositions for controlled delivery of soluble receptors. (1996) (0)
Antibodies to nod, their generation, and the use (2004) (0)
Löslisches extracellular fragment of human metallic IFN-beta 2 / IL-6 receptor, its preparation and this fragment containing pharmaceutical mixture (1990) (0)
SS8-1 The ‘apoptotic’ caspases as regulators of inflammation: new lessons from the study of caspase-8 function (2010) (0)
A method of determining interferon and reagent for performing the method (1980) (0)
anti-NIK antibodies and their uses (2004) (0)
845 High mortality and delayed onset of proliferation after partial hepatectomy in transgenic mice expressing dominant negative MORT1/FADD in hepatocytes (2003) (0)
Use of a caspase-8 inhibitors to modulating hematopoiesis (2006) (0)
Modulations of Fas / Apo1-receptors function (1995) (0)
Levels of soluble receptors for tumor necrosis factor type I and type II in paired synovial fluids of arthritis patients (2004) (0)
47 Regulation of Inflammation and Cell-Death Trough Interactions of RHIM-domain Protein Kinases With Caspase-8 (2012) (0)
Expression of recombinant tumor necrosis factor binding protein I (TBP-I) (1990) (0)
Faculty of 1000 evaluation for NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. (2018) (0)
Compositions for modulating the effects of TNF and IL-1. (1987) (0)
Faculty Opinions recommendation of Phosphorylation of NLRC4 is critical for inflammasome activation. (2012) (0)
Faculty Opinions recommendation of IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. (2007) (0)
The role of mort1/FADD in apoptosis and liver regeneration (2003) (0)
Tumor necrosis factor suppressive proteins and their purification (1988) (0)
Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
Faculty Opinions recommendation of Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. (2009) (0)
Pharmaceutical compositions for the controlled release of oplöselige receptors (1996) (0)
THE NF‐KB SIGNALING CASCADE AND HUMAN PATHOLOGIES: 179 (2004) (0)
ELEVATED LEVELS OF TUMOR NECROSIS FACTOR (TNF) IN ADOLESCENTS ON HEMODIALYSIS (HD) (1987) (0)
A monoclonal antibody against a cytotoxin, the same producing hybridomas and methods for preparing the purified cytotoxin. (1985) (0)
Faculty Opinions recommendation of Noncanonical inflammasome activation by intracellular LPS independent of TLR4. (2013) (0)
Pharmaceutical preparations containing a cytokine. (1992) (0)
Keeping inflammation at bay Cells dying by apoptosis can trigger an anti-inflammatory gene response in other cells by releasing a compound called adenosine monophosphate. (2014) (0)
Faculty Opinions recommendation of Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. (2001) (0)
Regulation of Cell-Death and Immune Defense by receptors of the TNF/NGF family (2006) (0)
FAS / APO1 receptor activity modulators (1997) (0)

This paper list is powered by the following services:

Other Resources About David Wallach

en.wikipedia.org

What Schools Are Affiliated With David Wallach?

David Wallach is affiliated with the following schools:

Image Attributions

Image Source for David Wallach